AUTL - Wall Street Estimates - Autolus Therapeutics plc

Healthcare - Biotechnology - NASDAQ - GB

$ 1.725

-0.289 %

$ 459 M

Market Cap

-1.41

P/E

Price Target Average

430.43%

Revenue Forecast Estimate

576.46%

EBIT Estimate

--39.16%

Net Income Estimate

30.93%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets Autolus Therapeutics plc

Wall Street analysts predict an average 1-year price target for AUTL of $9.15 , with forecasts ranging from a low of $7.6 to a high of $11 .

AUTL Lowest Price Target Wall Street Target

7.6 USD 340.58%

AUTL Average Price Target Wall Street Target

9.15 USD 430.43%

AUTL Highest Price Target Wall Street Target

11 USD 537.68%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Free